Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 4,210 | 4,078 | 2,868 | 4,994 | 2,261 |
| Operating Income | -4,210 | -4,078 | -2,868 | -4,994 | -2,261 |
| Interest Expense | 2 | 1 | 2 | 3 | 2 |
| Other Income | 0 | 0 | -135 | 0 | 0 |
| Pre-tax Income | -4,212 | -4,079 | -3,005 | -4,997 | -2,263 |
| Income Tax | -2 | 5 | N/A | N/A | -2 |
| Net Income Continuous | -4,210 | -4,084 | -3,005 | -4,997 | -2,261 |
| Net Income | $-4,215 | $-4,079 | $-3,005 | $-4,997 | $-2,265 |
| EPS Basic Total Ops | -6.01 | -1.80 | -7.51 | -15.92 | -8.41 |
| EPS Basic Continuous Ops | -5.50 | -1.84 | -6.49 | -15.17 | -7.51 |
| EPS Diluted Total Ops | -6.01 | -1.80 | -7.51 | -15.92 | -8.41 |
| EPS Diluted Continuous Ops | -5.50 | -1.84 | -6.49 | -15.17 | -7.51 |
| EBITDA(a) | $-4,195 | $-4,062 | $-2,849 | $-5,034 | $-2,174 |